Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-01-06 @ 3:10 PM
Study NCT ID:
NCT01589094
Status:
COMPLETED
Last Update Posted:
2019-10-02
First Post:
2012-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2018-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-27
First Submit QC Date:
None
Study First Post Date:
2012-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-22
Results First Submit QC Date:
None
Results First Post Date:
2019-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-01
Last Update Post Date:
2019-10-02
Last Update Post Date Type:
ACTUAL